Metraipolis › archive › dc_dbd078b5f2df

A novel approach to interrogating the effects of chemical warfare agent exposure using organ-on-a-chip technology and multiomic analysis — Europe PMC PMID:36780485

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36780485
DOI
10.1371/journal.pone.0280883
License (as archived)
CC0-1.0
Archived
2026-10-07T14:56:32.055Z
SHA-256 of the archived text
f1dc0969c9e7bd70921ee3fe9660738ad40d563d64ef551d40d18780f2ab76a5
Stable URL of this page
https://metraipolis.com/documento/dc_dbd078b5f2df

How to cite

A novel approach to interrogating the effects of chemical warfare agent exposure using organ-on-a-chip technology and multiomic analysis — Europe PMC PMID:36780485 — Europe PMC (en), https://europepmc.org/article/MED/36780485 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_dbd078b5f2df (Metraipolis archive dc_dbd078b5f2df, sha256 f1dc0969c9e7bd70921ee3fe9660738ad40d563d64ef551d40d18780f2ab76a5)
BibTeX
@misc{dcdbd078b5f2df,
  title = {A novel approach to interrogating the effects of chemical warfare agent exposure using organ-on-a-chip technology and multiomic analysis — Europe PMC PMID:36780485},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36780485},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_dbd078b5f2df; sha256 f1dc0969c9e7bd70921ee3fe9660738ad40d563d64ef551d40d18780f2ab76a5},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36780485. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Organ-on-a-chip platforms are utilized in global bioanalytical and toxicological studies as a way to reduce materials and increase throughput as compared to in vivo based experiments. These platforms bridge the infrastructure and regulatory gaps between in vivo animal work and human systems, with models that exemplify active biological pathways. In conjunction with the advent of increased capabilities associated with next generation sequencing and mass spectrometry based '-omic' technologies, organ-on-a-chip platforms provide an excellent opportunity to investigate the global changes at multiple biological levels, including the transcriptome, proteome and metabolome. When investigated concurrently, a complete profile of cellular and regulatory perturbations can be characterized following treatment with specific agonists. In this study, global effects were observed and analyzed following liver chip exposure to the chemical warfare agent, VX. Even though the primary mechanism of action of VX (i.e. acetylcholinesterase inhibition) is well characterized, recent in vivo studies suggest additional protein binding partners that are implicated in metabolism and cellular energetic pathways. In addition, secondary toxicity associated with peripheral organ systems, especially in human tissues, is not well defined. Our results demonstrate the potential of utilizing an organ-on-a-chip platform as a surrogate system to traditional in vivo studies. This is realized by specifically indicating significant dysregulation of several cellular processes in response to VX exposure including but not limited to amino acid synthesis, drug metabolism, and energetics pathways.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-02-13).
Identificativi: PMID 36780485 · PMCID PMC9925079 · DOI 10.1371/journal.pone.0280883.
Descrittori MeSH principali: Chemical Warfare Agents.
Pagina: https://europepmc.org/article/MED/36780485 — https://doi.org/10.1371/journal.pone.0280883. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T14:29:45.806Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.